These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20207503)

  • 1. Brachytherapy in the treatment of cholangiocarcinoma.
    Shinohara ET; Guo M; Mitra N; Metz JM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.
    Shinohara ET; Mitra N; Guo M; Metz JM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1191-8. PubMed ID: 19201549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
    Gerhards MF; van Gulik TM; González González D; Rauws EA; Gouma DJ
    World J Surg; 2003 Feb; 27(2):173-9. PubMed ID: 12616432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
    Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of intrahepatic cholangiocarcinoma--a population-based study.
    Tan JC; Coburn NG; Baxter NN; Kiss A; Law CH
    Ann Surg Oncol; 2008 Feb; 15(2):600-8. PubMed ID: 17987347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
    Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
    Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases.
    Zhang HY; Kong YL; Zhang HY; He XJ; Zhang H; Liu CL; Zhao G; Xiao M; Zhang XD; Feng ZQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):418-21. PubMed ID: 18693179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
    Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
    Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
    Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
    Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.